4-Bromoindole: Advancing Neuropharmacology and Oncology Research
NINGBO INNO PHARMCHEM CO.,LTD. is a key supplier of specialized chemicals that drive innovation in critical research areas. Among these is 4-Bromoindole (CAS 52488-36-5), a compound gaining significant attention for its role in advancing neuropharmacology and oncology research, primarily due to its potential as a GSK-3 inhibitor.
Glycogen synthase kinase-3 (GSK-3) is a kinase enzyme that plays a crucial role in numerous cellular pathways. Aberrant GSK-3 activity has been linked to neurodegenerative diseases such as Alzheimer's and Parkinson's, as well as various forms of cancer. Consequently, compounds that can modulate GSK-3 activity are of immense interest to researchers developing new therapeutic strategies. 4-Bromoindole's function as a potential GSK-3 inhibitor positions it as a valuable tool for these investigations. Researchers can utilize this intermediate to synthesize derivatives with enhanced specificity and efficacy, aiming to develop targeted treatments.
The application of 4-Bromoindole in these fields underscores its importance as a pharmaceutical intermediate. The ability to reliably synthesize complex molecules such as clavicipitic acid or other indole-based drug candidates is essential. NINGBO INNO PHARMCHEM CO.,LTD. provides high-purity 4-Bromoindole, ensuring that researchers have access to a dependable starting material for their demanding synthetic protocols. Understanding the specific CAS 52488-36-5 chemical properties, including its reactivity and stability, is fundamental for successful experimental design.
The growing field of neuropharmacology benefits greatly from compounds that can interact with neurological pathways. As an indole derivative, 4-Bromoindole shares structural similarities with neurotransmitters and other neurologically active molecules, making it a promising scaffold for developing treatments for neurological disorders. Similarly, in oncology, the manipulation of cellular signaling pathways is a cornerstone of cancer therapy. 4-Bromoindole's potential to inhibit GSK-3 makes it relevant for exploring new avenues in cancer drug discovery, contributing to the broader category of brominated indole derivatives for drug discovery.
For academic institutions and pharmaceutical companies engaged in cutting-edge research, the availability of specialized organic synthesis building blocks like 4-Bromoindole is critical. NINGBO INNO PHARMCHEM CO.,LTD. is committed to supplying these essential materials, supporting scientific advancement. Whether you are investigating new treatments for neurodegenerative diseases or developing novel cancer therapies, our 4-Bromoindole is produced to high standards. We invite researchers and procurement specialists to purchase 4-Bromoindole from NINGBO INNO PHARMCHEM CO.,LTD. for their critical projects, ensuring quality and reliability in every batch.
Perspectives & Insights
Quantum Pioneer 24
“is a key supplier of specialized chemicals that drive innovation in critical research areas.”
Bio Explorer X
“Among these is 4-Bromoindole (CAS 52488-36-5), a compound gaining significant attention for its role in advancing neuropharmacology and oncology research, primarily due to its potential as a GSK-3 inhibitor.”
Nano Catalyst AI
“Glycogen synthase kinase-3 (GSK-3) is a kinase enzyme that plays a crucial role in numerous cellular pathways.”